Diebold Nixdorf (DBD) Tops Q4 EPS by 8c
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $67.08 -2.32%
Financial Fact:
Total cost of sales: 424.9M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Total cost of sales: 424.9M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q4 EPS of $0.44, $0.08 better than the analyst estimate of $0.36. Revenue for the quarter came in at $1.11 billion versus the consensus estimate of $1.07 billion.
GUIDANCE:
Diebold Nixdorf sees 2021 revenue of $4-4.1 billion, versus the consensus of $4.09 billion.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- BMO Capital Starts Lululemon (LULU) at Underperform
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
